Hiding in plain sight - platelets, the silent carriers of HIV-1.
Yvonne BaumerTina M WeatherbyBrooks I MitchellIvo N SahBandarThomas A PremeauxD'Antoni Michelle LCristhian A Gutierrez-HuertaTiffany M Powell-WileyTimothy R BrownWilliam A BoisvertCecilia M ShikumaLishomwa C NdhlovuPublished in: Platelets (2020)
There are approximately 38 million people globally living with Human immunodeficiency virus 1 (HIV-1) and given the tremendous success of combination antiretroviral therapy (cART) this has dramatically reduced mortality and morbidity with prevention benefits. However, HIV-1 persists during cART within the human body and re-appears upon cART interruption. This HIV-1 reservoir remains a barrier to cure with cellular sites of viral persistence not fully understood. In this study we provide evidence corroborating a recently published article in STM demonstrating the role of platelets as a novel cellular disseminator of HIV-1 particles in the setting of viral suppression. Using classical transmission electron microscopy with and without immunogold labeling, we visualize HIV-1 in both platelets and monocytes in cART suppressed HIV donors. Our study suggests that due to the close proximity of platelets and monocytes an alternative life cycle of HIV-1 cycling within monocytes and platelets without the need of active replication under cART occurs. Our findings are supported by the lack of detectable HIV-1 particles in platelets derived from HIV uninfected donors or the 'Berlin' patient suggesting that platelets may serve as an underappreciated hidden bearer for HIV-1 and should be considered in HIV remission studies and trials.
Keyphrases
- antiretroviral therapy
- human immunodeficiency virus
- hiv infected
- hiv positive
- hiv aids
- hiv testing
- hepatitis c virus
- hiv infected patients
- men who have sex with men
- south africa
- cardiovascular disease
- type diabetes
- dendritic cells
- systemic lupus erythematosus
- rheumatoid arthritis
- cardiovascular events
- risk factors
- immune response
- disease activity
- coronary artery disease
- randomized controlled trial